Cleveland Clinic Endocrinology & Metabolism Institute
Avatar

Diabetes and Increased Cancer Risk: What Are the Mechanisms That Explain This Association?

By Cleveland Clinic Endocrinology & Metabolism Institute FEATURING Derek LeRoith
By Cleveland Clinic Endocrinology & Metabolism Institute FEATURING Derek LeRoith
127 views
February 3, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Related Content

AUTOPLAY
47:11
Houston Methodist Hospital

The Protein Myth: Our Obsession With Protein and How It Is Killing US

Feat. G. Davis
64:45
Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

Primer on Diabetes Management

Feat. S. Inzucchi
49:21
Physicians Committee for Responsible Medicine

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Feat. T. J. Key
23:35
Practical Ways to Achieve Targets in Diabetes Care

Is There a Future for HbA1c? (Moving Towards CGM: GMI and TIR)

Feat. I. Hirsch
15:06
Robert Busch

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

37:21
University of Colorado Department of Medicine

Evidence that Obesity and Diabetes are Driven by a Diet-Induced Biol…

Feat. R. Johnson
12:26
Juan Frias

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

15:33
Ken Fujioka

Could GLP-1's be a 'Game Changer' For Weight Loss? Ca…

17:44
Rita Jermyn

SGLT2 Inhibitors: For Heart Failure, Diabetes, and Renal Disease

06:51
Susan Brian

Discussing SURMOUNT Trials: Tirzepatide for Weightloss

26:32
Practical Ways to Achieve Targets in Diabetes Care

Metabolic Surgery vs. Pharmacotherapy for Treatment of Obesity

Feat. S. Nissen
26:49
Diana Isaacs

Tirzepatide Updates

44:43
Jason Fung

Type 2 Diabetes Aetiology and Reversibility

19:26
Krista Varady

ADA 2022 Flipping the Metabolic Switch: Intermittent Fasting as a We…

05:08
Susan Brian

The Differences Between the Products of GLP1's and GLP/GIPs

23:21
Practical Ways to Achieve Targets in Diabetes Care

TIR vs. A1c: Q&A/ Panel Discussion

Feat. J. Skyler, G. Aleppo, T. Danne, L. Barbour
06:31
Susan Brian

Discussing Retatrutide: A GIP, GLP-1, and Glucagon Receptor Agonist

18:49
INOVA

Home Ultrasound: Revolutionaizing Antenatal Management

Feat. A. Wiznitzer
05:40
Susan Brian

An Introduction to Tirzepatide for Weightloss

33:23
Keck School of Medicine of USC

Effects of Low Calorie and Alternative Sweeteners Across the Lifespa…

Feat. M. Goran